Detalhe da pesquisa
1.
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother
; 72(3): 775-782, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998004
2.
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
Cancer
; 127(6): 840-849, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216356